Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

FDA verdict on Amgen’s Humira biosimilar due in September

Begins review the version of AbbVie's big-selling anti-inflammatory drug

- PMLiVE

Pharma trio join with top universities for new drug search

AZ, GSK and J&J join forces with Imperial, University College and Cambridge

- PMLiVE

Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

He takes up a seat on the company's board of directors

- PMLiVE

Dr George Gunn moves from Novartis to join Nuritas

The Irish biotech also adds to its advisory board

National Institute for Health and Care Excellence NICE logo

NICE backs BMS’ Opdivo for melanoma

Recommendation comes despite the Institute rejecting the drug for lung cancer

Threat of medical device hacking is ‘growing concern’

FDA issues new cybersecurity guidance to help minimise risks

- PMLiVE

Dr Jessie English joins Merck

She will take up the role of vice president of its discovery team

- PMLiVE

NHS taps technology firms for ‘connected’ patient projects

One of the pilots will see Google's Verily unit work with MSD on a telehealth initiative

Avanir Pharmaceuticals appoints new president and CEO

Rohan Palekar succeeds Keith Katkin

Can Cinderella save us?

Pharma sector musters for new antibiotic search

Calls for greater government-industry collaboration on antibiotic-resistant infections

- PMLiVE

Lucid moves into new stateside premises

Med ed agency expands its US base

- PMLiVE

Alkermes depression drug misses targets in phase III

Irish firm suffers major research setback with ALKS 5461

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links